Rituximab in Membranous Nephropathy: Is It a First-Line Treatment?

被引：8
|
作者：
Appel, Gerald B. [1 ]
机构：
[1] Columbia Univ, Med Ctr, Columbia Univ Coll Phys & Surg, Dept Med,Div Nephrol, New York, NY 10032 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 08期
关键词：
THERAPY; ANTIGEN;
D O I：
10.1681/ASN.2012060602
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1280 / 1282
页数：3
相关论文
共 50 条
  • [41] Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma
    Jain, Preetesh
    Zhao, Shuangtao
    Lee, Hun Ju
    Hill, Holly A.
    Ok, Chi Young
    Kanagal-Shamanna, Rashmi
    Hagemeister, Fredrick B.
    Fowler, Nathan
    Fayad, Luis
    Yao, Yixin
    Liu, Yang
    Moghrabi, Omar B.
    Navsaria, Lucy
    Feng, Lei
    Gonzalez, Graciela M. Nogueras
    Xu, Guofan
    Thirumurthi, Selvi
    Santos, David
    Iliescu, Cezar
    Tang, Guilin
    Medeiros, L. Jeffrey
    Vega, Francisco
    Avellaneda, Michelle
    Badillo, Maria
    Flowers, Christopher R.
    Wang, Linghua
    Wang, Michael L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 202 - +
  • [42] Novel treatment options in rituximab-resistant membranous nephropathy patients
    Ahmadian, Elham
    Khatibi, Seyed Mahdi Hosseiniyan
    Vahed, Sepideh Zununi
    Ardalan, Mohammadreza
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 107
  • [43] Belimumab and Rituximab for the Treatment of Primary Membranous Nephropathy: Initial REBOOT Results
    Nachman, Patrick H.
    Stelzig, Lia
    Sherman, Matthew A.
    Barry, William T.
    Chung, Sharon
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [44] First-line treatment of TAFRO syndrome with rituximab: a case report and literature review
    Servati, Salar
    Mohammadi, Ida
    Firouzabadi, Shahryar Rajai
    ANNALS OF HEMATOLOGY, 2025,
  • [45] Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial
    Kadatz, Matthew
    Klarenbach, Scott
    So, Helen
    Fervenza, Fernando C.
    Cattran, Daniel C.
    Barbour, Sean J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (12) : 2058 - 2066
  • [46] SINGLE AGENT RITUXIMAB IS A VALID OPTION FOR FIRST-LINE TREATMENT IN FOLLICULAR LYMPHOMA
    Ghielmini, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 81 - 81
  • [47] NEW ONSET PSORIASIS AFTER RITUXIMAB FOR TREATMENT OF IDIOPATHIC MEMBRANOUS NEPHROPATHY
    Mok, Maggie Ming Yee
    Yeung, Chi Keung
    Chan, Daniel Tak Mao
    Lo, Wai Kei
    NEPHROLOGY, 2014, 19 (01) : 60 - 60
  • [48] Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Schiattone, Luana
    Bartalucci, Giulia
    Bocchia, Monica
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2997 - 2998
  • [49] Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy
    Cheong, Jamie
    Ooi, Khai
    CLINICAL KIDNEY JOURNAL, 2018, 11 (01) : 51 - 53
  • [50] EARLY TREATMENT WITH RITUXIMAB IN RECURRENT MEMBRANOUS NEPHROPATHY AFTER KIDNEY TRANSPLANT
    Agrawal, Nikhil
    Adapa, Sreedhar
    Konala, Venu Madhav
    Dhingra, Hemant
    Pavlakis, Martha
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 646 - 646
12345